DMS Group's Annual Performance and Results for 2025

DMS Group recorded organic growth of 8.5% in 2025, with revenue reaching €50 million. EBITDA increased by 69% to €4.6 million, reflecting improved margins and effective cost management.

This performance is attributed to international expansion, particularly in North America with 71% growth, and to partnerships in mobile radiology. Conversely, Europe experienced an 8% decline in market share.

With positive results and a solid financial boost, notably thanks to a €6.9 million fundraising round, DMS plans to outperform the medical imaging market despite geo-economic uncertainties.